Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer
Saidu Sani, Melissa Messé, Quentin Fuchs, et al.
ChemBioChem (2020) Vol. 22, Iss. 7, pp. 1151-1160
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field
Beatrice Stefanie Ludwig, Horst Kessler, Susanne Kossatz, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1711-1711
Open Access | Times Cited: 164
Using Chemistry To Recreate the Complexity of the Extracellular Matrix: Guidelines for Supramolecular Hydrogel–Cell Interactions
Laura Rijns, Matthew B. Baker, Patricia Y. W. Dankers
Journal of the American Chemical Society (2024) Vol. 146, Iss. 26, pp. 17539-17558
Open Access | Times Cited: 22
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Nimeet Desai, Deepak Kumar Sahel, Bhakti Kubal, et al.
Advanced Therapeutics (2025)
Open Access | Times Cited: 3
Bioactive peptides from microalgae: Focus on anti‐cancer and immunomodulating activity
Kari Skjånes, Reidun Aesöy, Lars Herfindal, et al.
Physiologia Plantarum (2021) Vol. 173, Iss. 2, pp. 612-623
Open Access | Times Cited: 78
Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy
Yongguang Gao, Xinhua Liu, Na Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 178-178
Open Access | Times Cited: 38
Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy
Junhua Li, Quan Zhao, Nan Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 13226-13240
Closed Access | Times Cited: 17
Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications
Ute Reuning, Vincenzo Maria D’Amore, Kairbaan Hodivala‐Dilke, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108193-108193
Closed Access | Times Cited: 1
Targeting tumor microenvironment with RGD-functionalized nanoparticles for precision cancer therapy
Sara Lorenzoni, Carlos Rodríguez‐Nogales, María J. Blanco‐Prieto
Cancer Letters (2025), pp. 217536-217536
Closed Access | Times Cited: 1
Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy
Yin Li-yan, X Li, Rongrong Wang, et al.
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 4
Open Access | Times Cited: 17
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery
Roberta Solidoro, Antonella Centonze, Morena Miciaccia, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1800-1866
Closed Access | Times Cited: 8
Application of Photoactive Compounds in Cancer Theranostics: Review on Recent Trends from Photoactive Chemistry to Artificial Intelligence
Patryk Szymaszek, Małgorzata Tyszka‐Czochara, Joanna Ortyl
Molecules (2024) Vol. 29, Iss. 13, pp. 3164-3164
Open Access | Times Cited: 8
Pure DNA scaffolded drug delivery systems for cancer therapy
Hanane Aliouat, Ying Peng, Zoya Waseem, et al.
Biomaterials (2022) Vol. 285, pp. 121532-121532
Closed Access | Times Cited: 25
Nanomaterials as Theranostic Agents for Cancer Therapy
Sudepta Bauri, Swikriti Tripathi, Avishek Mallick Choudhury, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 23, pp. 21462-21495
Closed Access | Times Cited: 15
RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics
Kenji Mishiro, Sayaka Imai, Yuki Ematsu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16741-16753
Closed Access | Times Cited: 22
Photosensitizer-based small molecule theranostic agents for tumor-targeted monitoring and phototherapy
Jiake Gao, Hongfei Jiang, Pengwei Chen, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106554-106554
Open Access | Times Cited: 11
Mimicking the extracellular world: from natural to fully synthetic matrices utilizing supramolecular biomaterials
Laura Rijns, Martin G. T. A. Rutten, Annika F. Vrehen, et al.
Nanoscale (2024) Vol. 16, Iss. 35, pp. 16290-16312
Open Access | Times Cited: 4
Current status and future perspective of radiopharmaceuticals in China
Hu Ji, Hongyu Li, Yanying Sui, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 8, pp. 2514-2530
Open Access | Times Cited: 25
The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
Jiang Liu, Junchao Zhang, Xun Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2870-2870
Open Access | Times Cited: 11
Multifunctional small-molecule theranostic agents for tumor-specific imaging and targeted chemotherapy
Renshuai Zhang, Hao Li, Pengwei Chen, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106576-106576
Closed Access | Times Cited: 11
RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells
Fatemeh Khosravani, Fatemeh Amiri, Rouzbeh Mahmoudi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 2347-2357
Closed Access | Times Cited: 10
Overcoming Immune Checkpoint Inhibitor Resistance via Potent and Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides
Anna Lechner, Peter A. Jordan, Gabriella Costa Machado da Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Exploring the therapeutic potential of ligand-decorated nanostructured lipid carriers for targeted solid tumor therapy
Zrien Naz, Mohammad Fareed, Abdur Rahman Hamidullah Chaudhary, et al.
International Journal of Pharmaceutics (2025) Vol. 678, pp. 125687-125687
Closed Access
Glutamine‐derived peptides: Current progress and future directions
Tianfei Yu, T. Hu, Kai Na, et al.
Comprehensive Reviews in Food Science and Food Safety (2024) Vol. 23, Iss. 4
Closed Access | Times Cited: 3
Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptide
Renwei Jing, Qian Wang, Lu Chen, et al.
Biomaterials (2022) Vol. 289, pp. 121758-121758
Open Access | Times Cited: 14
RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences
Johannes Notni
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 56-56
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top